AKBA vs AMGN: Which Stock is Better?
Side-by-side comparison of Akebia Therapeutics Inc and Amgen Inc in 2026
AKBA
Akebia Therapeutics Inc
$1.55
AMGN
Amgen Inc
$348.22
Key Metrics Comparison
| Metric | AKBA | AMGN | Winner |
|---|---|---|---|
| Market Cap | $417.89M | $189.19B | AMGN |
| P/E Ratio | N/A | 24.70 | AMGN |
| EPS (TTM) | $N/A | $14.21 | AMGN |
| Revenue Growth | 0.2% | 0.1% | AKBA |
| Gross Margin | 82.9% | 70.8% | AKBA |
Analyze AKBA
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AKBA or AMGN a better investment?
Comparing AKBA and AMGN: Akebia Therapeutics Inc has a market cap of $417.89M while Amgen Inc has $189.19B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AKBA and AMGN?
AKBA (Akebia Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AKBA or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AKBA or AMGN?
AKBA has higher revenue growth at 0.2% vs 0.1% for AMGN.
Which company is more profitable: AKBA or AMGN?
Akebia Therapeutics Inc (AKBA) has higher gross margins at 82.9% compared to 70.8% for AMGN.
Which is the larger company: AKBA or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $189.19B compared to $417.89M for AKBA.
Should I buy AKBA or AMGN in 2026?
Both AKBA and AMGN have investment merit. AKBA trades at $1.55 while AMGN trades at $348.22. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AKBA and AMGN stock?
Key differences: Market Cap ($417.89M vs $189.19B), P/E Ratio (N/A vs 24.7x), Revenue Growth (0.2% vs 0.1%), Gross Margin (82.9% vs 70.8%).